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Fungal pathogens represent a leading cause of life-threaten-
ing infections in debilitated patients and exert a substantial
toll on health care resources. A major development in the
past few years, resulting from extremely rapid technological
advances, has been the elucidation of the genome sequences
of all of the major human fungal pathogens. Together with
the development of transcriptomics and proteomics, fungal
pathogen research has entered the so-called “omics” era.
However, despite the remarkable acceleration in the under-
standing of many molecular mechanisms underlying phe-
nomenasuchasdrugresistance,fungalvirulence,andpatho-
genesis, many key aspects of the host-fungal interactions are
still not fully understood.
This current issue provides in-depth review articles
drafted by international experts tackling diﬀerent perspec-
tives of the host-pathogen interplay. Their contributions
oﬀer insights into aspects related to fungal virulence and
drug resistance of both established and emerging fungal
pathogens, as well as models to study their pathogenicity.
The paper by G. P. Moran and colleagues explains why
Candidaalbicanshasevolvedtobecomesuchasuccessfulop-
portunistic pathogen, by comparative global gene expression
analysis performed on C. albicans and its most closely related
species C. dubliniensis.
The epidemiology of invasive fungal infections has
evolved over the past twenty years. Yeasts other than C.
albicans and moulds other than Aspergillus fumigatus have
emerged as signiﬁcant causes of invasive mycoses in severely
immunocompromised patients. Tools allowing a prompt
diagnosis for these emerging pathogenic fungi are lacking,
often leading to a delay in eﬀective treatment and high mor-
tality rates. This is the case for invasive mucormycosis, a
rapidly progressing infection often refractory to antifungal
therapy, with a negative prognosis in individuals with im-
pairedimmunedefence.Thekeyroleofironuptake,angioin-
vasion, and neurotropism in the virulence repertoire of this
fascinating group of fungi is reviewed by G. Morace and E.
Borghi.
Chitinisoneofthemostabundantbiopolymersinnature
andcomprisespartofthefungalcellwallstructure.Although
humans do not biosynthesize chitin, they do express chitin
degradingenzymes.Thetargetedrecognitionoffungalchitin
by the host may have implications for diagnostic assays, as
wellasforpotentialnewtherapeuticapproaches.Thisemerg-
ing topic is reviewed by K. Vega and M. Kalkum. Another
major process that inﬂuences fungal cell wall structure is
protein glycosylation, which is essential for eukaryotic cells.
However, the mechanisms by which carbohydrates play a
role in the development of fungal diseases are still poorly
characterised. In this context, C. Jin provides an overview on
the contribution of protein glycosylation to growth, cell wall
synthesis and development in A. fumigatus, possibly provi-
ding a novel strategy for drug development.
Histoplasma capsulatum is a major fungal pathogen en-
demic to the Americas, exhibiting a broad variety of clini-
cal presentations, ranging from mild lung infection to life-
threatening systemic infections. The severity of infection and
its outcome result from a complex interaction between the
virulence repertoire of the pathogen and the host’s immune
defences. The paper by M. R. Mihu and J. D. Nosanchuk2 International Journal of Microbiology
focuses on the dynamic host-pathogen interplay in the con-
text of the virulence arsenal displayed by the fungus and the
innate and adaptive immune responses of the host.
The molecular mechanisms underlying the ability of der-
matophytes to establish infection and persist in the host are
reviewed by R. R. Achterman and T. C. White. Despite the
fact that this group of ﬁlamentous fungi are the most com-
mon cause of cutaneous mycoses, very little is known about
dermatophyte pathogenesis. The paper presents the current
research status on dermatophyte virulence factors.
The ability of fungal cells to chemically communicate
with each other and with other microorganisms has only
recently been discovered. The paper by F. Cottier and F.
A. M¨ uhlschlegel depicts a fascinating picture of a closely
connected microbial community in the environment, where
multispecies communication takes place. Versatile fungal
communicative competences are thought to have a signif-
icant impact on several fungal biological functions such as
mating, growth, or the regulation of virulence factor expres-
sion. Among the latter, hyphal formation has been widely
recognised to signiﬁcantly contribute to the pathogenesis of
several fungal species, by promoting adhesion to biotic or
abiotic surfaces and tissue penetration. The paper by A.
Brand presents the current knowledge on C. albicans hyphal
growth during infection, addressing the issue of speciﬁc
functions and mechanical/structural properties conferred by
hyphal formation during infection.
Fungal pathogens have evolved complex mechanisms of
resistance to antifungal drugs. The nature, frequency, and
molecular mechanisms of resistance to currently used anti-
fungals are the focus of the review by P. Vandeputte and col-
leagues, who also describe the latest approaches to develop
new antifungal strategies.
A growing number of fungal pathogens have been associ-
ated with life-threatening infections resulting from bioﬁlm-
related infections that are particularly diﬃcult to treat. In-
deed, bioﬁlm-embedded fungal cells are far more resistant
to antifungal agents than their corresponding planktonic
cells. The molecular basis of this remarkable resistance to
antifungals has yet to be fully elucidated. In this respect,
G. Ramage and coworkers review the latest ﬁndings on this
topic and shed new light on the multifactorial nature of
bioﬁlm antifungal resistance. From a diﬀerent perspective,
H. Tournu and P. Van Dijck describe some of the most recent
approaches shown to eradicate Candida bioﬁlms, based on
novel strategies to evaluate bioﬁlm formation in vitro and in
vivo.
The choice of the most appropriate experimental infec-
tion model to use for fungal pathogenesis-, virulence-,
immunology-, and therapy-based studies is critical. In this
issue, several contributions were made towards this topic.
Mucosal and systemic models of Candida infection and
virulence are discussed in depth by D. M. MacCallum, while
the range of experimental models currently available for
cryptococcosis is reviewed by W. Sabiiti and coworkers. G.
Hamilos and colleagues oﬀe rac r i t i c a la n a l y s i so ft h eu s eo f
Drosophila melanogaster as a surrogate model to study the
immunopathogenesis of fungal infection and illustrate the
recent advances in the study of medically important ﬁlamen-
tous fungi in Drosophila.
Bioluminescent imaging is a powerful tool to perform
real time evaluation of temporal and spatial progression of
infections. Mainly used for the study of bacterial infection
process, M. Brock discusses the application of biolumines-
cent imaging to the study of mycoses, summarising the key
features of diﬀerent luciferase systems and providing sugges-
tions for future applications.
We believe that the collection of reviews authored by
experts in the ﬁeld presented here will provide a timely up-
date of recent rapid developments in the ﬁeld of medical
mycology. We hope that the reviews will be helpful in as-
sembling the interlocking pieces of the complex jigsaw that
is the fungal-host interplay, as well as provide a basis for the
generation of novel ideas and hypotheses for future experi-
mentation.
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